Valuation: Acarix AB

Market Cap 31Cr 3.22Cr 2.82Cr 2.6Cr 2.44Cr 4.57Cr 303.86Cr 4.67Cr 12Cr 150.18Cr 12Cr 12Cr 520.74Cr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 31Cr 3.22Cr 2.82Cr 2.6Cr 2.44Cr 4.57Cr 303.86Cr 4.67Cr 12Cr 150.18Cr 12Cr 12Cr 520.74Cr EV / Sales 2026 *
16.4x
EV / Sales 2027 * 4.5x
Free-Float
80.16%
Yield 2026 *
-
Yield 2027 * -
1 day-2.98%
1 week+7.24%
Current month+1.24%
1 month-1.21%
3 months-8.94%
6 months-11.89%
Current year-5.23%
1 week 0.02
Extreme 0.0152
0.02
1 month 0.02
Extreme 0.0152
0.02
Current year 0.02
Extreme 0.0152
0.04
1 year 0.02
Extreme 0.0152
0.04
3 years 0.01
Extreme 0.0112
0.05
5 years 0.01
Extreme 0.0112
0.17
10 years 0.01
Extreme 0.0112
2.37
Manager TitleAgeSince
Chief Executive Officer - 01/02/2024
Chief Operating Officer 62 01/12/2009
Chief Executive Officer 62 23/02/2018
Director TitleAgeSince
Director/Board Member 61 01/01/2020
Director/Board Member 50 14/05/2024
Director/Board Member - 14/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
-2.98%+7.24% - - 3.22Cr
-2.69%+5.16%+1.13%-23.26% 1.61TCr
-5.09%-7.73%+19.11%+46.11% 144.13Cr
-0.65%-1.61%-32.31%+28.51% 109.27Cr
+2.00%+0.88%-52.23%-82.99% 94Cr
-4.81%-9.65%-26.43%-54.80% 61Cr
-4.26%+1.87%-39.12%-56.01% 56Cr
0.00%-2.28%+19.93%-54.91% 43Cr
-1.57%0.00%-54.96%-59.97% 38Cr
-2.02%-0.58%-24.94%-23.68% 33Cr
Average -2.21%-2.29%-21.09%-31.22% 243.06Cr
Weighted average by Cap. -2.56%+2.81%-4.45%-21.66%

Financials

2026 *2027 *
Net sales 1.91Cr 19.66L 17.24L 15.89L 14.88L 27.9L 19Cr 28.48L 73.91L 9.17Cr 73.83L 72.22L 32Cr 6.95Cr 71.55L 62.73L 57.82L 54.14L 1.02Cr 67Cr 1.04Cr 2.69Cr 33Cr 2.69Cr 2.63Cr 115.66Cr
Net income -2.89Cr -29.75L -26.09L -24.04L -22.51L -42.21L -28Cr -43.09L -1.12Cr -14Cr -1.12Cr -1.09Cr -48Cr 24L 2L 2L 2L 2L 4L 2.33Cr 4L 9L 1.15Cr 9L 9L 3.99Cr
Net Debt - -
Logo Acarix AB
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Employees
8
Date Price Change
26/26/26 €0.0163 -2.98%
25/26/25 €0.0168 +2.44%
24/26/24 €0.0164 +1.86%
23/26/23 €0.0161 -0.62%
22/26/22 €0.0162 +6.58%

Quarterly revenue - Rate of surprise